Related Experiment Video
Updated: Jun 25, 2025
12:32
High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
12.0K
MicroRNA 29 modulates β-cell mitochondrial metabolism and insulin secretion via underlying miR-29-OXPHOS complex
E Cowan1, J Sun2, A Hamilton1,3
1Unit of Islet Cell Exocytosis, Department of Clinical Sciences Malmö, Lund University Diabetes Centre, Lund University, Lund, Sweden.
Acta Physiologica (Oxford, England)
|May 27, 2024
Summary
MicroRNA-29 (miR-29) plays a crucial role in regulating beta-cell mitochondrial function and insulin secretion. Reduced miR-29 expression enhances insulin secretion, potentially as a compensatory mechanism in glucotoxicity.
Area of Science:
- Endocrinology
- Molecular Biology
- Mitochondrial Biology
Background:
- MicroRNAs (miRNAs) are critical regulators of beta-cell function.
- Mitochondrial dysfunction and impaired insulin secretion characterize diabetes.
- Identifying key miRNAs involved in beta-cell mitochondrial metabolism is essential.
Purpose of the Study:
- To identify key miRNAs regulating beta-cell mitochondrial metabolism.
- To elucidate novel beta-cell miRNA-mitochondrial pathways.
- To investigate the role of miR-29 in beta-cell function and mitochondrial activity.
Main Methods:
- Bioinformatic prediction of miRNA-target interactions using TargetScan.
- Measurement of miRNA expression and insulin secretion in INS-1 832/13 cells under varying glucose conditions.
- Assessment of insulin secretion, mitochondrial complex I gene expression, and oxidative phosphorylation (OXPHOS) in miR-29 silenced cells.
- Evaluation of miR-29 expression in islets from diabetic models (GK rat, db/db mouse) and human type 2 diabetic (T2D) islets.
Main Results:
- MiR-29, miR-15, and miR-124 were predicted to target mitochondrial cis-eGenes, with miR-29 targeting at least 12.
- Reduced miR-29 expression and insulin secretion were observed in cells cultured in elevated glucose.
- MiR-29 knockdown enhanced insulin secretion, mitochondrial complex I and II expression, and OXPHOS.
- MiR-29 expression patterns varied across different diabetic models and conditions.
Conclusions:
- MiR-29 is a key regulator of beta-cell mitochondrial metabolism and insulin secretion through miR-29-OXPHOS pathways.
- Reduced miR-29 expression appears to be a compensatory mechanism that enhances insulin secretion under glucotoxicity.
- These findings highlight miR-29 as a potential therapeutic target for diabetes.
More Related Videos
Related Concept Videos
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:28Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
01:28The Inner Mitochondrial Membrane
3.3K
The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...
3.3K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
01:05Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K